Migraine With or Without Aura

4

Review clinical trials related to Migraine With or Without Aura. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults

The purpose of this study is to evaluate the long-term safety of BR005-036C tablets in the acute treatment of migraines

Participants needed: 1,000
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Brise Pharmaceuticals Co., Ltd.Updated: Sep 25, 2026Locations: 81
Eligibility criteria

Male or female Participants aged 18 years or older. [+4]

Patient with a history of or diagnosed with brainstem aura migraine, hemiplegic... [+9]

Status: Not yet recruiting

A Study to Learn About the Study Medicine NURTEC® ODT 75 mg After it is Released Into the Markets in Korea

The purpose of this study is to evaluate safety and effectiveness of NURTEC® ODT 75 mg (Rimegepant sulfate) in adult patients with acute treatment of migraine with or without aura and with preventive treatment of episodic migraine during the PMS period as required by the Korean ministry of food and drug safety (MFDS).

Participants needed: 3,000
Trial details
Age: 19+Biological sex: AllType: ObservationalSponsor: PfizerUpdated: Sep 25, 2026
Eligibility criteria

Subjects aged 19 years or older [+2]

Status: Not yet recruiting

Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults

The purpose of this study is to compare the efficacy and safety of BR005-036C versus placebo in subjects with Acute Migraines

Participants needed: 2,079
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Brise Pharmaceuticals Co., Ltd.Updated: Sep 16, 2026Locations: 83
Eligibility criteria

Male or female Participants aged 18 years or older. [+5]

Patient with a history of or diagnosed with brainstem aura migraine, hemiplegic... [+9]

Status: Recruiting

New Methods for Evaluating Preventive Migraine Treatment

The study aims to test interactions between drug and placebo-responses in acute migraine treatment and to assess variation in adverse events according to treatment information provided. Using a clinical within-subjects, balanced placebo design, patients with chronic migraine will receive four treatment conditions in a randomized order.

Participants needed: 60
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: University of AarhusUpdated: May 19, 2026Locations: 2
Eligibility criteria

Adults (18-65 years) [+4]

Use of onabotulinumtoxinA as preventive migraine treatment during the 4 months b... [+6]